U.S. Markets close in 4 hrs 7 mins

Free Post Earnings Research Report: Approach Resources Reported Q4 and Full Year FY17 Results

LONDON, UK / ACCESSWIRE / April 19, 2018 / Active-Investors.com has just released a free earnings report on Approach Resources, Inc. (NASDAQ: AREX). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=AREX. The Company posted its financial results on March 08, 2018, for the fourth quarter of the fiscal year 2017 (Q4 FY17) and for the full fiscal year 2017 (FY17). The Company's oil, natural liquids (NGLs), and gas sales increased y-o-y during the reported quarter, but missed Wall Street's estimates. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Approach Resources most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=AREX

Earnings Highlights and Summary

During Q4 FY17, Approach Resources' oil, NGLs, and gas sales came in at $28.42 million, which were 11% higher than the $26.51 million recorded at the end of Q4 FY16. The Company's Oil, NGLs, and gas sales numbers for the reported quarter fell short of market consensus estimates of $28.7 million.

The oil and gas Company reported a net income of $45.82 million, or $0.51 per diluted share, in Q4 FY17 compared to a net loss of $13.48 million, or $0.32 loss per diluted share, in Q4 FY16. The Company's adjusted net loss narrowed to $6.07 million, or $0.07 loss per diluted share, in Q4 FY17 from an adjusted net loss of $9.73 million, or $0.23 loss per diluted share, in the prior year's same quarter. Market analysts had also forecasted the Company to report an adjusted net loss of $0.07 per diluted share in Q4 FY17.

For the full year FY17, Approach Resources' revenues stood at $105.35 million compared to $90.30 million in FY16. The Company's net loss was $112.36 million, or $1.35 loss per diluted share, in FY17 versus a net loss of $52.24 million, or $1.26 loss per diluted share, in FY16. Furthermore, the Company reported an adjusted net loss of $29.81 million, or $0.36 loss per diluted share, in FY17 compared to $42.50 million, or $1.02 loss per diluted share, in FY16.

Operating Metrics

The Fort Worth, Texas-based Company's total expenses decreased to $29.37 million during Q4 FY17 from $33.56 million in the past year's comparable quarter. The Company posted an operating loss of $0.95 million during Q4 FY17 compared to an operating loss of $7.06 million in Q4 FY16. Furthermore, the Company's earnings before interest, taxes, depreciation, depletion, amortization, and exploration expenses (EBITDAX) stood at $13.89 million in Q4 FY17 compared to $15.47 million in Q4 FY16.

For Q4 FY17, Approach Resources' oil production volume fell to 270 thousand barrels (MBbls) from 304 MBbls in Q4 FY16. The oil average realized price was $52.09 per bbl during the reported quarter, up from $46.02 per bbl in the previous year's corresponding quarter.

The Company's quarterly production volume of NGLs totaled 377 MBbls in Q4 FY17, which was lower than 380 MBbls in the prior year's same quarter. The Company's average NGLs realized price was $22.61 per bbl in Q4 FY17 compared to $15.25 per bbl in Q4 FY16.

Approach Resources' gas production volume also increased to 2,498 million cubic feet per day (MMcf/d) during Q4 FY17 from 2,530 MMcf/d in Q4 FY16. Furthermore, the Company's gas average realized was $2.32 per Mcf in Q4 FY17 compared to $2.65 per Mcf in Q4 FY16.

Approach Resources' total production was 1,064 thousand barrels of oil equivalent per day (MBOE/d) during the reported quarter compared to 1,106 MBOE in Q4 FY16. Meanwhile, the Company's total daily production was 11.6 MBOE/d during Q4 FY17 versus 12.0 MBOE/d in Q4 FY16.

Cash Matters and Balance Sheet

For the full fiscal year ended December 31, 2017, Approach Resources generated net cash provided by operating activities of $37.45 million compared to $26.08 million in the prior year. Moreover, the Company's net capital expenditure totaled $47.1 million incurred during FY17.

The Company's cash and cash equivalents balance stood flat at $0.02 million as on December 31, 2017. Furthermore, the Company's net long-term debt was down to $373.46 million as on December 31, 2017, from $498.35 million as on December 31, 2016.

Stock Performance Snapshot

April 18, 2018 - At Wednesday's closing bell, Approach Resources' stock climbed 3.68%, ending the trading session at $2.82.

Volume traded for the day: 1.92 million shares, which was above the 3-month average volume of 498.90 thousand shares.

Stock performance in the last month – up 10.59%; previous six-month period – up 21.03%; and past twelve-month period – up 24.23%

After yesterday's close, Approach Resources' market cap was at $261.39 million.

The stock is part of the Basic Materials sector, categorized under the Independent Oil & Gas industry. This sector was up 1.8% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

  • iPhone XR: Apple finally explains latest handset's strange name
    Technology
    The Independent

    iPhone XR: Apple finally explains latest handset's strange name

    Apple has finally explained its strange iPhone naming system this year. When the new phones came out, the XS felt fairly natural. Apple had never used the letter before, and it wasn't clear why they'd chosen the name – whether it was simply the letter before S, or referred to something else entirely.

  • Business
    Motley Fool

    Parsing Visa's Big Quarterly Dividend Hike

    The ubiquitous financial services player Visa (NYSE: V) isn't exactly an income stock -- its dividend yield has fairly consistently been below 1% for years. Which raises two interesting questions for MarketFoolery host Chris Hill and senior analyst Jason Moser. In this segment from MarketFoolery, they discuss Visa's cash cow structure, its stock repurchases, and the M&A possibilities it thus far seems to be ignoring.

  • Suze Orman missed the point of retirement, and that’s why she went back to work
    News
    MarketWatch

    Suze Orman missed the point of retirement, and that’s why she went back to work

    Suze Orman did a smackdown of the FIRE (Financial Independence/Retire Early) movement on Paula Pant’s podcast. Coach Carson posted a balanced, informative response, appreciating Suze’s admonition to be sure you have enough for a risk-free retirement. Suze enumerated a string “what can go wrong” scenarios as evidence that early retirement (on less than $10 million) leaves you vulnerable when life hands you lemons — a whole tree of lemons.

  • 5 Deeply Discounted Value Stocks That Haven't Been This Cheap in at Least a Decade
    Business
    Motley Fool

    5 Deeply Discounted Value Stocks That Haven't Been This Cheap in at Least a Decade

    October has been a wake-up call for investors that the stock market won't go up in a straight line, even if we'd like it to. Sure, Bank of America (NYSE: BAC) has seen its stock catapult higher from its Great Recession lows, but its forward P/E of 9.8 would represent a more-than-decade low for the stock.

  • Stocks plunge, Dow drops more than 500 points
    Finance
    Yahoo Finance

    Stocks plunge, Dow drops more than 500 points

    US equities took a nosedive Tuesday, extending a rout in global stocks. The Dow (^DJI) slid 2.08%, or 526.84 points, as of 10:17 a.m. ET, as major manufacturers Caterpillar and 3M posted disappointing financial results. The S&P 500 (^GSPC) fell 2.28%,

  • Why Investors Are Paying a Premium for These 3 Biotech Stocks
    Business
    Motley Fool

    Why Investors Are Paying a Premium for These 3 Biotech Stocks

    Amarin stock exploded in September because it looks like Vascepa will become the next go-to drug for this enormous population. During the 8,179-patient Reduce-It trial, patients given Vascepa in addition to their normal statin treatments were 25% less likely to suffer a major cardiovascular event such as a heart attack. Over the past year, Amarin Corporation actually lost $92 million because sales of Vascepa just haven't kept pace with operating expenses.

  • Finance
    CNBC

    Here's the tax bite on $1.6 billion Mega Millions and $620 million Powerball jackpots

    Strategies can be employed to reduce the amount of your win that is taxed, although they are best explored with the help of an experienced tax advisor. While it's anyone's guess who will end up winning the Mega Millions and Powerball jackpots, there's at least one guaranteed recipient of a chunk of the loot — the IRS. With the Mega Millions jackpot at $1.6 billion and Powerball's top prize at $620 million, that tax bill will be hefty even if the winner employs strategies to reduce their taxable income.

  • MoviePass to be jettisoned by parent company
    Business
    Associated Press

    MoviePass to be jettisoned by parent company

    MoviePass, the struggling discount movie ticket subscription service, is being spun off by the company that owns it. Helios and Matheson Analytics Inc. did not try to obscure the reasons why on Tuesday. MoviePass has become a burden.

  • These stocks may be sacrificed in a cold war with China
    COL
    CNBC Videos

    These stocks may be sacrificed in a cold war with China

    Jim Cramer says the escalation in the United States' trade war with China could end in an outright cold war that debilitates parts of the stock market.

  • 4 Things Aurora Cannabis Did Right Before Its NYSE Debut
    Business
    Motley Fool

    4 Things Aurora Cannabis Did Right Before Its NYSE Debut

    Aurora Cannabis (NASDAQOTH: ACBFF) (TSX: ACB) has sought to make it even easier for U.S. investors to buy its shares by arranging to have its shares listed on the New York Stock Exchange. Beginning tomorrow, Oct. 23, Aurora will join the elite group of cannabis companies whose shares trade on major U.S. exchanges. Getting ready for the increased exposure that a NYSE listing brings takes time and effort, and Aurora Cannabis hasn't wasted any time.

  • The stock market's 'dead cat bounce' is over and the rolling bear market is making a comeback, Morgan Stanley says
    Business
    Business Insider

    The stock market's 'dead cat bounce' is over and the rolling bear market is making a comeback, Morgan Stanley says

    The stock market may have bounced back from its sharp sell-off at the beginning of October, but Morgan Stanley says the selling will pick back up soon. The firm expects the S&P 500 to slide back below the 200-day moving average, a key technical level. Tread carefully in tech and consumer discretionary, Morgan Stanley warns.

  • McDonald’s Beats Sales Estimates Again
    Business
    Bloomberg

    McDonald’s Beats Sales Estimates Again

    Key InsightsMcDonald’s, which gets nearly two-thirds of revenue from overseas, said comparable sales in its international lead markets division that includes Australia and the U.K. topped estimates, rising 5.4 percent. “The changes McDonald’s is making are right and will pay dividends over time,” Neil Saunders, managing director of GlobalData Retail, said in an email.

  • Polaris Shrugs Off Tariff Concerns With Another Impressive Quarter
    Business
    Motley Fool

    Polaris Shrugs Off Tariff Concerns With Another Impressive Quarter

    Polaris Industries Inc. (NYSE: PII) announced third-quarter 2018 results early on Monday, detailing encouraging demand for its newest products, the first contributions from its recent acquisition of pontoon boat specialist Boat Holdings, and its view on recent tariff and trade concerns. With Polaris stock climbing as much as 8% early today before settling to close up 2.3%, let's dig deeper to see how the off-road vehicle specialist fared as it kicked off the second half. What happened with Polaris this quarter?

  • News
    CNBC

    Here's how much money you should have saved by 50

    Fidelity, the nation's largest retirement-plan provider, recommends having the equivalent of six times your annual salary saved. To get to that number, Fidelity recommends saving 15 percent of your annual income. Make sure to invest these funds instead of leaving them in a traditional low-interest savings account.

  • Dow tumbles nearly 550 points at lows amid corporate outlook, China selloff
    News
    MarketWatch

    Dow tumbles nearly 550 points at lows amid corporate outlook, China selloff

    It was a punishing start for stocks Tuesday as investors reacted negatively to quarterly results from a handful of blue chips and the cessation of a two-day rebound for China’s embattled stock market, reviving fresh questions about global economic growth prospects. The Dow Jones Industrial Average (DJIA) 548.62 points at its low and remained was recently 460 points, or 1.8%, at 24,862. The S&P 500 (SPX) fell 55 points, or 2%, to 2,696, retreating below a psychological and technical mark at 2,700, while the Nasdaq Composite Index (COMP) slid gave up 177 points, or 2.4%, to 7,291.

  • Trump’s Tax Push to Help Middle Class Could Help Top Earners Too
    Politics
    Bloomberg

    Trump’s Tax Push to Help Middle Class Could Help Top Earners Too

    It’s still unclear how Trump will propose to reduce the tax burden on middle-class Americans, but one of the most straightforward ways would be to lower rates by 10 percent for single filers making up to $82,500. U.S. income tax rates are graduated and income dollars get taxed in chunks as they move up through the brackets -- which means wealthy Americans would also get to apply the reduced rate on their first dollars of income. “A millionaire gets the same size tax cut,” said Kyle Pomerleau, an economist at the conservative Tax Foundation.

  • Shares of downtrodden IBM 'ready to roar higher': Charts
    Business
    CNBC Videos

    Shares of downtrodden IBM 'ready to roar higher': Charts

    Jim Cramer and technician Larry Williams inspect the charts of IBM, which seem to show the beleaguered tech stock on the cusp of a rally.

  • Why American Railcar Industries, PetMed Express, and Dynavax Technologies Jumped Today
    Business
    Motley Fool

    Why American Railcar Industries, PetMed Express, and Dynavax Technologies Jumped Today

    Monday was another mixed day on Wall Street, as most major large-cap indexes posted losses even as the tech-heavy Nasdaq Composite again bucked the downtrend and traded higher for much of the session.

  • Are AMD Investors Overreacting to Intel’s CPU Supply Update?
    Finance
    Market Realist

    Are AMD Investors Overreacting to Intel’s CPU Supply Update?

    Are AMD Investors Overreacting to Intel’s News? (Continued from Prior Part) The 2018 CPU story of AMD and Intel The Advanced Micro Devices-Intel CPU (central processing unit) story is taking an interesting twist in 2018 as Intel faces CPU supply shortage

  • Why Pot Stocks Canopy Growth, Cronos Group, and Tilray Are Cratering Today
    Business
    Motley Fool

    Why Pot Stocks Canopy Growth, Cronos Group, and Tilray Are Cratering Today

    Canadian pot stocks are getting hit hard across the board today. As of 1:21 p.m. EDT, for example, shares of Canopy Growth Corporation (NYSE: CGC) and Cronos Group (NASDAQ: CRON) were both down by 11.2%, whereas Tilray's(NASDAQ: TLRY) stock had fallen by 14.4%. Canopy, Cronos, and Tilray all seem to be succumbing to a so-called "sell the news" event.

  • What to Expect from Bristol-Myers Squibb’s Q3 Earnings
    Finance
    Market Realist

    What to Expect from Bristol-Myers Squibb’s Q3 Earnings

    Bristol-Myers Squibb (BMY) is expected to report its third-quarter earnings on October 25. Analysts expect Bristol-Myers Squibb’s revenues to increase 8.87% from $5.25 billion in the third quarter of 2017 to $5.72 billion in the third quarte of 2018. In the last four quarters, Bristol-Myers Squibb’s revenue growth has been 3.93%–10.89%.

  • Why Nektar Therapeutics Crashed 17.2% Today
    Business
    Motley Fool

    Why Nektar Therapeutics Crashed 17.2% Today

    After delivering a disappointing update on NKTR-214 in cancer patients this summer, Nektar Therapeutics' (NASDAQ: NKTR) shares have been struggling. The company didn't report any news today, so a negative report issued by Plainview LLC this month may be to blamed for its 17.2% tumble today. In February, Bristol-Myers Squibb (NYSE: BMY) inked a blockbuster deal to license rights to NKTR-214 following positive data last year for NKTR-214's use alongside Bristol-Myers' Opdivo.

  • One of the largest cannabis companies is going public on the New York Stock Exchange
    Business
    Business Insider

    One of the largest cannabis companies is going public on the New York Stock Exchange

    Aurora Cannabis, one of the largest Canadian marijuana producers, is going public on the New York Stock Exchange. Aurora is joining a select list of Canadian cannabis producers, including Tilray and Cronos, that are able to list on US-based exchanges.

  • Caterpillar's shares tumble on disappointing profit outlook
    Business
    Reuters

    Caterpillar's shares tumble on disappointing profit outlook

    Caterpillar Inc (CAT.N) disappointed investors on Tuesday by not raising its 2018 earnings forecast yet again, raising fears that the heavy-duty equipment maker may be signaling a slowdown despite posting better-than-expected quarterly profits. The Dow Jones Industrial Average (.DJI), which includes Caterpillar, was down about 440 points on Tuesday. The company kept unchanged the 2018 adjusted profit per share outlook of $11.00 to $12.00 per share, which did not go down well with investors who were expecting yet another upward revision in the earnings guidance.

  • Marijuana Stocks Plummet to Record Low: What's Next?
    Business
    Zacks

    Marijuana Stocks Plummet to Record Low: What's Next?

    Over the last few days, share prices of major marijuana stocks have plummeted to their worst in the trailing eight months. This free fall commenced following the legalization of marijuana for recreational use in Canada on Oct 17.Legalization Considered